Blood disorders affect millions of Americans, yet many don’t realize these conditions can sometimes transform into something far more serious. With approximately 1.3 million people currently living ...

A Roche drug in development for treating a rare blood disorder has Phase 3 data showing it worked at least as well as a blockbuster AstraZeneca drug while also offering patients a dosing advantage.

This month the FDA has approved a treatment for an inherited blood disorder. The Casgevy treatment was developed through CRISPR gene-editing technology and involves modifying a person’s own blood stem ...

Reblozyl has stumbled on its quest to reach a wider pool of blood disorder patients. Bristol Myers Squibb is pulling the plug on Reblozyl’s bid to treat anemia in adults with non-transfusion-dependent ...

The National Institute for Health and Care Excellence (NICE) has recommended exagamglogene autotemcel (Casgevy, Vertex) – commonly known as 'exa-cel' – to treat transfusion-dependent beta thalassaemia ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

Could your heavy flow be cause for concern? Sherri Ozawa, MSN, RN, tells The Post that serious blood loss during menstruation could be a symptom of Von Willebrand disease (VWD), a blood disorder that ...